Sandra M. Swain
0000-0002-1320-3830
Publication & Citation Trends
Publications
546 total
Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA study OA
Cited by 1
Semantic Scholar
Pharmacokinetics (PK) and pharmacogenomics (PGx) of ribociclib (ribo) in Black patients with metastatic breast cancer (mBC): The LEANORA study.
Cited by 0
Semantic Scholar
Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data Availability.
Cited by 3
Semantic Scholar
Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation. OA
Cited by 4
Semantic Scholar
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Cited by 872
OpenAlex
SAFE-HEaRt: A pilot study assessing the cardiac safety of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function.
Cited by 8
Semantic Scholar
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials PDF
Cited by 1,115
OpenAlex
Research Topics
Cancer Treatment and Pharmacology
(196)
HER2/EGFR in Cancer Research
(195)
Breast Cancer Treatment Studies
(192)
Advanced Breast Cancer Therapies
(101)
Estrogen and related hormone effects
(48)
Affiliations
Roche (Switzerland)
MedStar Washington Hospital Center
George Washington University Hospital
American Cancer Society
Fox Chase Cancer Center